Literature DB >> 15184649

Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.

Geeta Chaudhri1, Vijay Panchanathan, R Mark L Buller, Alfons J M van den Eertwegh, Eric Claassen, Jie Zhou, Rosalind de Chazal, Jon D Laman, Gunasegaran Karupiah.   

Abstract

Ectromelia virus (ECTV), a natural mouse pathogen and an orthopoxvirus, has been used to investigate the correlation between polarized type 1 or type 2 immune responses and resistance to disease in poxvirus infections by using well defined resistant and susceptible mouse strains. Our data show that distinct differences exist in the cytokine profiles expressed in resistant and susceptible mice infected with ECTV. Resistant C57BL/6 mice generate a type 1 cytokine response [IFN-gamma, IL-2, and tumor necrosis factor (TNF)], within the first few days of infection, which is associated with strong cytotoxic T lymphocyte response (CTL) and recovery from ECTV infection. Susceptible strains of mice (BALB/c and A/J) on the other hand generate a type 2 cytokine response (IL-4 but little or no IFN-gamma and IL-2), which is associated with a weak or an absent CTL response, resulting in uncontrolled virus replication and death. Although deletion of IL-4 function alone did not change the outcome of infection in susceptible mice, the loss of IFN-gamma function in resistant mice abrogated natural killer (NK) cell and CTL effector functions resulting in fulminant disease and 100% mortality. Therefore, a clear link exists between the early production of specific type 1 cytokines, in particular, IFN-gamma, the nature of the cellular immune response, and disease outcome in this virus model. This finding in the mousepox model raises the possibility that inappropriate cytokine responses may result in increased susceptibility to smallpox in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184649      PMCID: PMC428472          DOI: 10.1073/pnas.0402949101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.

Authors:  Tom H M Ottenhoff; Frank A W Verreck; Elgin G R Lichtenauer-Kaligis; Marieke A Hoeve; Ozden Sanal; Jaap T van Dissel
Journal:  Nat Genet       Date:  2002-09       Impact factor: 38.330

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice.

Authors:  H C O'Neill; M Brenan
Journal:  J Gen Virol       Date:  1987-10       Impact factor: 3.891

4.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity.

Authors:  P H Verardi; L A Jones; F H Aziz; S Ahmad; T D Yilma
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence.

Authors:  Julian A Symons; David C Tscharke; Nicola Price; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

7.  Restricted replication of ectromelia virus in cell culture correlates with mutations in virus-encoded host range gene.

Authors:  W Chen; R Drillien; D Spehner; R M Buller
Journal:  Virology       Date:  1992-04       Impact factor: 3.616

8.  Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.

Authors:  G Karupiah; B E Coupar; M E Andrew; D B Boyle; S M Phillips; A Müllbacher; R V Blanden; I A Ramshaw
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

9.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins.

Authors:  K Mossman; C Upton; R M Buller; G McFadden
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

View more
  51 in total

1.  Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.

Authors:  Vijay Panchanathan; Geeta Chaudhri; Gunasegaran Karupiah
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection.

Authors:  Isaac G Sakala; Geeta Chaudhri; R Mark Buller; Anthony A Nuara; Hongdong Bai; Nanhai Chen; Gunasegaran Karupiah
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity.

Authors:  Adam R Hersperger; Nicholas A Siciliano; Laurence C Eisenlohr
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.

Authors:  Helena Lynn; Jacquelyn Horsington; Lee Kuan Ter; Shuyi Han; Yee Lian Chew; Russell J Diefenbach; Michael Way; Geeta Chaudhri; Gunasegaran Karupiah; Timothy P Newsome
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

5.  Viral Replicative Capacity, Antigen Availability via Hematogenous Spread, and High TFH:TFR Ratios Drive Induction of Potent Neutralizing Antibody Responses.

Authors:  Preethi Eldi; Geeta Chaudhri; Stephen L Nutt; Timothy P Newsome; Gunasegaran Karupiah
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

6.  Crosstalk between autophagy and apoptosis in RAW 264.7 macrophages infected with ectromelia orthopoxvirus.

Authors:  Lech Martyniszyn; Lidia Szulc-Dąbrowska; Anna Boratyńska-Jasińska; Justyna Struzik; Anna Winnicka; Marek Niemiałtowski
Journal:  Viral Immunol       Date:  2013-10       Impact factor: 2.257

7.  A homolog of the variola virus B22 membrane protein contributes to ectromelia virus pathogenicity in the mouse footpad model.

Authors:  Sara E Reynolds; Patricia L Earl; Mahnaz Minai; Ian Moore; Bernard Moss
Journal:  Virology       Date:  2016-11-26       Impact factor: 3.616

8.  Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice.

Authors:  Henning Lauterbach; Ronny Kassub; Juliane Pätzold; Jana Körner; Michael Brückel; Admar Verschoor; Paul Chaplin; Mark Suter; Hubertus Hochrein
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

9.  Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.

Authors:  Nicholas A Siciliano; Adam R Hersperger; Aimee M Lacuanan; Ren-Huan Xu; John Sidney; Alessandro Sette; Luis J Sigal; Laurence C Eisenlohr
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  Induction of natural killer cell responses by ectromelia virus controls infection.

Authors:  April Keim Parker; Scott Parker; Wayne M Yokoyama; John A Corbett; R Mark L Buller
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.